Boral Anthony L. 4
4 · Blueprint Medicines Corp · Filed Oct 27, 2020
Insider Transaction Report
Form 4
Boral Anthony L.
Sr. VP, Clinical Development
Transactions
- Exercise/Conversion
Common Stock
2020-10-23$8.80/sh+3,409$29,999→ 28,147 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-10-23−5,774→ 0 totalExercise: $15.01Exp: 2026-02-03→ Common Stock (5,774 underlying) - Exercise/Conversion
Common Stock
2020-10-23$15.01/sh+5,774$86,668→ 24,738 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-10-23−3,409→ 0 totalExercise: $8.80Exp: 2025-02-10→ Common Stock (3,409 underlying)
Footnotes (2)
- [F1]This option was granted on February 3, 2016. This option is fully vested as of the date hereof.
- [F2]This option was granted on February 10, 2015. This option is fully vested as of the date hereof.